Merit Medical Systems, Inc.
NASDAQ:MMSIMedical - Instruments & Supplies
+$1.16 today
- Market cap
- $5.15B
- Beta
- 0.53
- P/E (TTM)
- 28.4
- EPS (TTM)
- $2.34
Volume 0.46M
Average 0.79M
MMSI Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Merit Medical Systems, Inc.NASDAQ: MMSI
Total Equity · Q3 FY2026 · quarter ended Sep 2026
Total equity rises 14.1% from a year ago
Total equity stood at $1.74B at the end of Q3 FY2026, up 14.1% from a year earlier and up 3.9% from the prior quarter. Over 3 fiscal years it compounded at +11.5% a year.
Context
- Total equity increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total equity keeps rising in the next quarterly balance sheet after a +14.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 1.58B USD
- Year-over-year change
- +14.9%
- 4-year CAGR
- +11.1%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.58B | +14.9% |
| FY2024 | 2024-12-31 | 1.38B | +14.8% |
| FY2023 | 2023-12-31 | 1.2B | +5.0% |
| FY2022 | 2022-12-31 | 1.14B | +10.1% |
| FY2021 | 2021-12-31 | 1.04B | — |
Total Equity vs competitors
How MMSI compares with its peers on the latest reported figures
- MMSI's Sep 2026 total equity of $1.74B is the 6th highest of the 10 companies compared; the peer median is $2.15B.
- Its year-over-year change of +14.1% is the 3rd highest of 10, against a peer median of +4.1%.
- Over three fiscal years its annual growth of +11.5% compares with a peer median of +0.5%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $25.17B | +11.1% | +11.7% | 55.7% | |
| Sep 2026 | $24.68B | -2.8% | -1.5% | 48.6% | |
| Jun 2026 | $4.8B | +31.7% | -24.5% | 33.7% | |
| Jun 2026 | $2.9B | -31.5% | -8.1% | 42.8% | |
| Jun 2026 | $2.15B | +1.7% | +0.5% | 54.2% | |
| Sep 2026 | $1.74B | +14.1% | +11.5% | — | |
| Mar 2026 | $1.02B | +4.1% | +11.5% | 44.0% | |
| Jun 2026 | $516.43M | +11.2% | +2.5% | 76.3% | |
| Mar 2026 | $406.62M | +17.0% | +13.6% | 64.6% | |
| Feb 2026 | $173.36M | -6.7% | -24.5% | 66.5% | |
| Peer median (excluding MMSI) | $2.15B | +4.1% | +0.5% | 54.2% | |
Competitors are the stored peer set for MMSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 67.75M | 58.41M | 587.04M | 376.72M | 448.5M |
| Short-term Investments | 0 | 0 | 2.1M | 0 | 0 |
| Net Receivables | 172.84M | 178.45M | 189.26M | 209.17M | 223.61M |
| Inventory | 221.92M | 265.99M | 303.87M | 306.06M | 333.71M |
| Other Current Assets | 16.15M | 22.32M | 22.19M | 28.54M | 29.39M |
| Total Current Assets | 482.21M | 529.08M | 1.11B | 923.77M | 1.04B |
| Property, Plant & Equipment (Net) | 437.57M | 448.24M | 446.57M | 451.67M | 516M |
| Goodwill | 361.74M | 359.82M | 382.24M | 463.51M | 506.84M |
| Intangible Assets | 319.27M | 275.87M | 325.88M | 498.27M | 537.65M |
| Long-term Investments | 14.71M | 15.58M | 19.06M | 22.83M | 45.66M |
| Tax Assets | 6.08M | 6.6M | 7.29M | 16.04M | 7.05M |
| Other Non-current Assets | 26.71M | 28.78M | 35.73M | 42.5M | 32.57M |
| Total Non-current Assets | 1.17B | 1.13B | 1.22B | 1.49B | 1.65B |
| Total Assets | 1.65B | 1.66B | 2.33B | 2.42B | 2.69B |
| Account Payables | 55.62M | 68.5M | 65.94M | 68.5M | 60.55M |
| Short-term Debt | 19.11M | 22.26M | 0 | 0 | 10.88M |
| Tax Payables | 2.54M | 6.7M | 5.09M | 3.49M | 4.94M |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 77.44M | 42.47M | 53.23M | 158K | 75.31M |
| Total Current Liabilities | 236.28M | 220.65M | 203.56M | 216.4M | 239.76M |
| Long-term Debt | 234.4M | 186.76M | 823.01M | 729.55M | 810.7M |
| Deferred Tax Liabilities | 31.5M | 18.46M | 5.55M | 240K | 19.67M |
| Deferred Revenue (Non-current) | 1.82M | 1.71M | 1.61M | 1.5M | 1.4M |
| Other Non-current Liabilities | 42.97M | 32.26M | 33.26M | 36.77M | (46.56M) |
| Total Non-current Liabilities | 372.22M | 298.92M | 919.68M | 822.84M | 861.85M |
| Total Liabilities | 608.5M | 519.57M | 1.12B | 1.04B | 1.1B |
| Common Stock | 641.53M | 675.17M | 638.15M | 703.22M | 763.91M |
| Retained Earnings | 406.26M | 480.77M | 575.18M | 695.54M | 824.03M |
| Accumulated OCI | (7.99M) | (11.55M) | (11.33M) | (19.4M) | (3.64M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.04B | 1.14B | 1.2B | 1.38B | 1.58B |
| Total Debt | 325.7M | 279.76M | 891.36M | 794.67M | 898.23M |
| Net Debt | 257.95M | 221.35M | 304.32M | 417.95M | 449.73M |
Merit Medical Systems, Inc.
NASDAQ:MMSI
Intrinsic Alpha fair value
Locked
Current Price
$85.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.